Wells Fargo
PBE icon

Wells Fargo’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Wells Fargo’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Sell
39,302
-7,554
-16% -$611K ﹤0.01% 2947
2025
Q4 		$3.85M Sell
46,856
-330
-0.7% -$25.5K ﹤0.01% 2922
2025
Q3 		$3.3M Sell
47,186
-24,543
-34% -$1.66M ﹤0.01% 2922
2025
Q2 		$4.6M Sell
71,729
-882
-1% -$54.6K ﹤0.01% 2544
2025
Q1 		$4.61M Sell
72,611
-1,693
-2% -$114K ﹤0.01% 2475
2024
Q4 		$4.94M Sell
74,304
-1,283
-2% -$88.4K ﹤0.01% 2455
2024
Q3 		$5.28M Buy
75,587
+1,884
+3% +$130K ﹤0.01% 2310
2024
Q2 		$4.78M Sell
73,703
-702
-0.9% -$44.5K ﹤0.01% 2285
2024
Q1 		$4.82M Sell
74,405
-23,491
-24% -$1.53M ﹤0.01% 2288
2023
Q4 		$6.45M Buy
97,896
+20,160
+26% +$1.17M ﹤0.01% 2034
2023
Q3 		$4.43M Sell
77,736
-749
-1% -$45.7K ﹤0.01% 2201
2023
Q2 		$4.81M Buy
78,485
+2,979
+4% +$186K ﹤0.01% 2177
2023
Q1 		$4.74M Sell
75,506
-1,514
-2% -$97.6K ﹤0.01% 2162
2022
Q4 		$4.89M Sell
77,020
-2,357
-3% -$150K ﹤0.01% 2105
2022
Q3 		$4.68M Buy
79,377
+16
+0% +$986 ﹤0.01% 2046
2022
Q2 		$4.58M Sell
79,361
-5,045
-6% -$291K ﹤0.01% 2164
2022
Q1 		$5.24M Sell
84,406
-19,472
-19% -$1.19M ﹤0.01% 2422
2021
Q4 		$7.4M Buy
103,878
+2,363
+2% +$171K ﹤0.01% 2144
2021
Q3 		$7.6M Sell
101,515
-930
-0.9% -$70.9K ﹤0.01% 2463
2021
Q2 		$7.92M Buy
102,445
+3,105
+3% +$231K ﹤0.01% 2430
2021
Q1 		$7.33M Buy
99,340
+3,250
+3% +$246K ﹤0.01% 2476
2020
Q4 		$6.74M Buy
96,090
+3,457
+4% +$219K ﹤0.01% 2452
2020
Q3 		$5.25M Buy
92,633
+39,351
+74% +$2.31M ﹤0.01% 2455
2020
Q2 		$3.1M Buy
53,282
+3,822
+8% +$208K ﹤0.01% 2901
2020
Q1 		$2.3M Sell
49,460
-11,827
-19% -$617K ﹤0.01% 2878
2019
Q4 		$3.42M Sell
61,287
-4,128
-6% -$215K ﹤0.01% 2892
2019
Q3 		$3.1M Sell
65,415
-28,731
-31% -$1.47M ﹤0.01% 2959
2019
Q2 		$5.04M Sell
94,146
-13,371
-12% -$694K ﹤0.01% 2569
2019
Q1 		$5.93M Sell
107,517
-5,969
-5% -$316K ﹤0.01% 2393
2018
Q4 		$5.34M Buy
113,486
+16,668
+17% +$857K ﹤0.01% 2380
2018
Q3 		$5.75M Buy
96,818
+11,252
+13% +$657K ﹤0.01% 2532
2018
Q2 		$4.68M Buy
85,566
+11,440
+15% +$582K ﹤0.01% 2748
2018
Q1 		$3.65M Sell
74,126
-6,768
-8% -$345K ﹤0.01% 2878
2017
Q4 		$3.81M Buy
80,894
+1,096
+1% +$51.4K ﹤0.01% 2826
2017
Q3 		$3.98M Buy
79,798
+4,737
+6% +$225K ﹤0.01% 2730
2017
Q2 		$3.43M Buy
75,061
+6,051
+9% +$261K ﹤0.01% 2755
2017
Q1 		$2.92M Sell
69,010
-6,198
-8% -$260K ﹤0.01% 2861
2016
Q4 		$2.92M Sell
75,208
-5,880
-7% -$237K ﹤0.01% 2857
2016
Q3 		$3.4M Buy
81,088
+4,902
+6% +$201K ﹤0.01% 2561
2016
Q2 		$2.82M Sell
76,186
-11,434
-13% -$448K ﹤0.01% 2729
2016
Q1 		$3.35M Sell
87,620
-9,349
-10% -$363K ﹤0.01% 2572
2015
Q4 		$4.9M Sell
96,969
-75,480
-44% -$3.73M ﹤0.01% 2341
2015
Q3 		$7.88M Sell
172,449
-13,411
-7% -$750K ﹤0.01% 1982
2015
Q2 		$10.8M Buy
185,860
+29,227
+19% +$1.67M ﹤0.01% 1847
2015
Q1 		$8.64M Sell
156,633
-12,011
-7% -$649K ﹤0.01% 1995
2014
Q4 		$8.47M Sell
168,644
-8,510
-5% -$416K ﹤0.01% 1940
2014
Q3 		$8.19M Sell
177,154
-201
-0.1% -$9.05K ﹤0.01% 1932
2014
Q2 		$7.75M Sell
177,355
-106,121
-37% -$4.3M ﹤0.01% 1990
2014
Q1 		$11.8M Buy
283,476
+28,903
+11% +$1.24M 0.01% 1660
2013
Q4 		$9.43M Buy
254,573
+133,105
+110% +$4.77M ﹤0.01% 1769
2013
Q3 		$4.26M Buy
121,468
+19,514
+19% +$646K ﹤0.01% 2313
2013
Q2 		$2.95M Buy
+101,954
New +$2.9M ﹤0.01% 2523

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Wells Fargo's PBE Position: Q1 2026 in Review

Wells Fargo reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 16% in Q1 2026, selling an estimated $611K and leaving 39,302 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2947.

Wells Fargo first reported a position in PBE in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.8M in Q1 2014. 100 funds tracked by Wall St. Rank hold PBE as of Q1 2026.

  • Wells Fargo held 39,302 shares of Invesco Biotechnology & Genome ETF worth $3.11M as of Q1 2026.
  • Wells Fargo sold 7,554 Invesco Biotechnology & Genome ETF shares in Q1 2026, an estimated $611K.
  • Invesco Biotechnology & Genome ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2947 holding.
  • Wells Fargo first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Invesco Biotechnology & Genome ETF position peaked at $11.8M in Q1 2014.
  • 100 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.